D.A. Davidson & CO. lifted its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 9.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 90,287 shares of the company’s stock after purchasing an additional 7,665 shares during the period. D.A. Davidson & CO.’s holdings in Colgate-Palmolive were worth $6,692,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of CL. TIAA CREF Investment Management LLC increased its stake in shares of Colgate-Palmolive by 84.2% during the 1st quarter. TIAA CREF Investment Management LLC now owns 4,554,989 shares of the company’s stock worth $333,380,000 after purchasing an additional 2,082,262 shares during the last quarter. Fiera Capital Corp boosted its holdings in Colgate-Palmolive by 17.3% in the 2nd quarter. Fiera Capital Corp now owns 4,595,453 shares of the company’s stock worth $340,662,000 after buying an additional 677,657 shares during the period. HAP Trading LLC boosted its holdings in Colgate-Palmolive by 109.1% in the 2nd quarter. HAP Trading LLC now owns 55,234 shares of the company’s stock worth $4,094,000 after buying an additional 662,067 shares during the period. Principal Financial Group Inc. boosted its holdings in Colgate-Palmolive by 45.1% in the 2nd quarter. Principal Financial Group Inc. now owns 1,843,728 shares of the company’s stock worth $136,676,000 after buying an additional 572,720 shares during the period. Finally, MARSHALL WACE ASIA Ltd boosted its holdings in Colgate-Palmolive by 1,419.1% in the 2nd quarter. MARSHALL WACE ASIA Ltd now owns 518,823 shares of the company’s stock worth $38,393,000 after buying an additional 484,670 shares during the period. Institutional investors own 73.46% of the company’s stock.
Colgate-Palmolive Company (NYSE CL) opened at $72.22 on Wednesday. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42. Colgate-Palmolive Company has a fifty-two week low of $63.43 and a fifty-two week high of $77.27. The company has a market cap of $63,285.04, a price-to-earnings ratio of 25.11, a price-to-earnings-growth ratio of 3.30 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same period in the previous year, the firm posted $0.73 EPS. The firm’s revenue was up 2.8% compared to the same quarter last year. equities research analysts anticipate that Colgate-Palmolive Company will post 2.88 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.
Several research analysts recently commented on CL shares. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a report on Thursday, August 24th. Macquarie started coverage on shares of Colgate-Palmolive in a report on Thursday, September 14th. They issued a “neutral” rating and a $76.00 price objective for the company. Morgan Stanley raised shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $75.00 to $84.00 in a report on Monday, September 25th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a report on Sunday, October 8th. One equities research analyst has rated the stock with a sell rating, fifteen have given a hold rating and four have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $76.67.
In related news, COO Justin Skala sold 126,393 shares of Colgate-Palmolive stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $72.97, for a total value of $9,222,897.21. Following the transaction, the chief operating officer now owns 262,361 shares in the company, valued at approximately $19,144,482.17. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Victoria L. Dolan sold 10,000 shares of Colgate-Palmolive stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $73.07, for a total transaction of $730,700.00. Following the completion of the transaction, the insider now owns 60,528 shares in the company, valued at approximately $4,422,780.96. The disclosure for this sale can be found here. Insiders have sold a total of 173,673 shares of company stock valued at $12,629,293 over the last ninety days. 1.02% of the stock is currently owned by insiders.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.